Erschienen in:
21.10.2022 | ASO Research Letter
Selective Internal Radiation Therapy (Yttrium-90 Glass Microspheres) Combined with Capecitabine in the Neoadjuvant Setting of Operable Intrahepatic CHOlangiocarcinoma: The SIROCHO Trial Design
verfasst von:
Julien Edeline, MD, PhD, Yan Rolland, MD, PhD, Boris Campillo-Gimenez, MD, Héloïse Bourien, MD, Marion Trochet, PhD, Etienne Garin, MD, PhD, Karim Boudjema, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 1/2023
Einloggen, um Zugang zu erhalten
Excerpt
Biliary tract cancers (BTCs) usually present an aggressive behavior, with a high risk of recurrence after resection with curative intent. The incidence of intrahepatic cholangiocarcinoma (ICC) is currently rising in Western countries. The current management of localized ICC is surgery. The BILCAP trial suggested improvement in overall survival (OS) with adjuvant capecitabine after resection of BTC, including ICC.
1 Some retrospective data suggest that neoadjuvant treatment might improve the results.
2 …